Julie Elaine Burke

Array ( [id] => 3616221 [patent_doc_number] => 05614191 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'IL-13 receptor specific chimeric proteins and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/404685 [patent_app_country] => US [patent_app_date] => 1995-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14177 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614191.pdf [firstpage_image] =>[orig_patent_app_number] => 404685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931595 [patent_doc_number] => 05928903 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Method for expressing recombinant genes in bacteria in absence of antibiotic selection' [patent_app_type] => 1 [patent_app_number] => 8/411778 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9733 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/928/05928903.pdf [firstpage_image] =>[orig_patent_app_number] => 411778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4059904 [patent_doc_number] => 05864019 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-26 [patent_title] => 'Multivalent antigen-binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/400115 [patent_app_country] => US [patent_app_date] => 1995-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 7968 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/864/05864019.pdf [firstpage_image] =>[orig_patent_app_number] => 400115 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3697137 [patent_doc_number] => 05618917 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Methods and compositions for detecting and treating kidney diseases associated with adhesion of crystals to kidney cells' [patent_app_type] => 1 [patent_app_number] => 8/389005 [patent_app_country] => US [patent_app_date] => 1995-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 15144 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618917.pdf [firstpage_image] =>[orig_patent_app_number] => 389005 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3885723 [patent_doc_number] => 05776895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock' [patent_app_type] => 1 [patent_app_number] => 8/376267 [patent_app_country] => US [patent_app_date] => 1995-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5016 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776895.pdf [firstpage_image] =>[orig_patent_app_number] => 376267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619641 [patent_doc_number] => 05612030 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma' [patent_app_type] => 1 [patent_app_number] => 8/372676 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5714 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612030.pdf [firstpage_image] =>[orig_patent_app_number] => 372676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733939 [patent_doc_number] => 05698424 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Capsid forming and cystein modified chimaeric MS2-coat protein' [patent_app_type] => 1 [patent_app_number] => 8/167982 [patent_app_country] => US [patent_app_date] => 1995-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 4174 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698424.pdf [firstpage_image] =>[orig_patent_app_number] => 167982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726677 [patent_doc_number] => 05635188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Anti-cancer vaccine' [patent_app_type] => 1 [patent_app_number] => 8/367682 [patent_app_country] => US [patent_app_date] => 1994-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6628 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635188.pdf [firstpage_image] =>[orig_patent_app_number] => 367682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3763828 [patent_doc_number] => 05844092 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-01 [patent_title] => 'Human TRK receptors and neurotrophic factor inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/359705 [patent_app_country] => US [patent_app_date] => 1994-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 47 [patent_no_of_words] => 36272 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/844/05844092.pdf [firstpage_image] =>[orig_patent_app_number] => 359705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3929849 [patent_doc_number] => 05877305 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'DNA encoding biosynthetic binding protein for cancer marker' [patent_app_type] => 1 [patent_app_number] => 8/356786 [patent_app_country] => US [patent_app_date] => 1994-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 14348 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877305.pdf [firstpage_image] =>[orig_patent_app_number] => 356786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732825 [patent_doc_number] => 05635603 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Preparation and use of immunoconjugates' [patent_app_type] => 1 [patent_app_number] => 8/352715 [patent_app_country] => US [patent_app_date] => 1994-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21963 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 364 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635603.pdf [firstpage_image] =>[orig_patent_app_number] => 352715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3517999 [patent_doc_number] => 05576423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Antibodies to the slam protein expressed on activated T cells' [patent_app_type] => 1 [patent_app_number] => 8/348792 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20774 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576423.pdf [firstpage_image] =>[orig_patent_app_number] => 348792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3734369 [patent_doc_number] => 05665865 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-09 [patent_title] => 'Metal binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/343658 [patent_app_country] => US [patent_app_date] => 1994-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 15325 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/665/05665865.pdf [firstpage_image] =>[orig_patent_app_number] => 343658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3642986 [patent_doc_number] => 05637323 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Method of mobilizing pluripotential hematopoietic stem cells with IL-7' [patent_app_type] => 1 [patent_app_number] => 8/341399 [patent_app_country] => US [patent_app_date] => 1994-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 14506 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637323.pdf [firstpage_image] =>[orig_patent_app_number] => 341399 [rel_patent_id] =>[rel_patent_doc_number] =>)